ArticleThe Indian journal of radiology & imaging2026
Role of Dynamic Perfusion CT in Pancreatic Adenocarcinoma.
Article in The Indian journal of radiology & imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Monte Carlo study of air ionization by X-ray photons and backscattering under diagnostic conditions using the developed Irradose code.Radiological physics and technology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: The aim of this study is to evaluate the utility of perfusion CT (PCT) in the diagnosis of pancreatic ductal adenocarcinoma (PDAC). Materials and Methods: In this ethically approved prospective study, PCT was performed in 71 patients with histologically proven PDAC. Perfusion parameters studied included blood flow (BF), blood volume (BV), permeability surface area product (PS), time to peak (TTP), peak enhancement intensity (PEI), and mean transit time (MTT). Forty-four controls with no pancreatic pathology were also studied. Results: Out of 71 patients, 43 (60.56%) were males and 28 (39.44%) were females, with male:female ratio of 1.54, and the mean age of the patients was 50.62 ± 13.86 years. The mean size of the masses was 4.47 ± 2.43 cm (range: 1.3-12 cm). Among the perfusion parameters, BF and BV were found to be the most reliable for the diagnosis of pancreatic adenocarcinoma. They were reduced in PDAC (BF: 19.54 ± 19.85 mL/100 mL/min and BV: 5.14 ± 3.82 mL/100 mL) as compared with normal controls (BF: 96.91 ± 39.09 mL/100 mL/min and BV: 30.45 ± 12.90 mL/100 mL) and the difference was statistically significant ( Conclusion: PCT parameters are useful in making an imaging diagnosis of PDAC and useful tool to detect isodense pancreatic masses. Approximated values of BF and BV perfusion parameters may serve as independent diagnostic predictors for the diagnosis of PDAC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.